Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Total Non-Current Liabilities (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Total Non-Current Liabilities for 7 consecutive years, with $149.3 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 9.51% to $149.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $149.3 million through Dec 2025, down 9.51% year-over-year, with the annual reading at $149.3 million for FY2025, 9.51% down from the prior year.
  • Total Non-Current Liabilities hit $149.3 million in Q4 2025 for Harmony Biosciences Holdings, roughly flat from $149.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $196.5 million in Q2 2021 to a low of $149.3 million in Q4 2025.
  • Historically, Total Non-Current Liabilities has averaged $179.0 million across 5 years, with a median of $183.0 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: rose 0.4% in 2022 and later fell 11.97% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $193.2 million in 2021, then fell by 0.52% to $192.1 million in 2022, then decreased by 5.97% to $180.7 million in 2023, then decreased by 8.7% to $165.0 million in 2024, then dropped by 9.51% to $149.3 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for HRMY at $149.3 million in Q4 2025, $149.7 million in Q3 2025, and $154.8 million in Q2 2025.